PT101079A - Processo para a preparacao de esteres prolinaboronatos - Google Patents

Processo para a preparacao de esteres prolinaboronatos Download PDF

Info

Publication number
PT101079A
PT101079A PT101079A PT10107992A PT101079A PT 101079 A PT101079 A PT 101079A PT 101079 A PT101079 A PT 101079A PT 10107992 A PT10107992 A PT 10107992A PT 101079 A PT101079 A PT 101079A
Authority
PT
Portugal
Prior art keywords
formula
pinanediol
group
compound
boronate
Prior art date
Application number
PT101079A
Other languages
English (en)
Portuguese (pt)
Inventor
Julian Adams
Roger Snow
Terence A Kelly
Simon Coutts
Clark Perry
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Publication of PT101079A publication Critical patent/PT101079A/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/02Boron compounds
    • C07F5/025Boronic and borinic acid compounds
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrrole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PT101079A 1991-11-22 1992-11-19 Processo para a preparacao de esteres prolinaboronatos PT101079A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US79614891A 1991-11-22 1991-11-22
US93619892A 1992-08-26 1992-08-26

Publications (1)

Publication Number Publication Date
PT101079A true PT101079A (pt) 1994-02-28

Family

ID=27121696

Family Applications (1)

Application Number Title Priority Date Filing Date
PT101079A PT101079A (pt) 1991-11-22 1992-11-19 Processo para a preparacao de esteres prolinaboronatos

Country Status (17)

Country Link
EP (1) EP0641347A1 (en:Method)
JP (1) JPH07501078A (en:Method)
CN (1) CN1073946A (en:Method)
AU (1) AU661362B2 (en:Method)
CA (1) CA2123128A1 (en:Method)
CZ (1) CZ124494A3 (en:Method)
FI (1) FI942345A0 (en:Method)
HU (1) HUT67937A (en:Method)
IL (1) IL103817A0 (en:Method)
MX (1) MX9206628A (en:Method)
NO (1) NO941905L (en:Method)
NZ (1) NZ245207A (en:Method)
PT (1) PT101079A (en:Method)
SI (1) SI9200332A (en:Method)
SK (1) SK59294A3 (en:Method)
TW (1) TW232697B (en:Method)
WO (1) WO1993010127A1 (en:Method)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6825169B1 (en) 1991-10-22 2004-11-30 Trustees Of Tufts College Inhibitors of dipeptidyl-aminopeptidase type IV
US5965532A (en) * 1996-06-28 1999-10-12 Trustees Of Tufts College Multivalent compounds for crosslinking receptors and uses thereof
US6100234A (en) * 1997-05-07 2000-08-08 Tufts University Treatment of HIV
US6040145A (en) 1997-05-07 2000-03-21 Tufts University Potentiation of the immune response
CN1163594C (zh) 1997-09-29 2004-08-25 尖端医疗有限公司 体外造血细胞的刺激
AU770319C (en) 1998-05-04 2004-11-25 Point Therapeutics, Inc. Hematopoietic stimulation
JP2002517401A (ja) 1998-06-05 2002-06-18 ポイント セラピューティクス, インコーポレイテッド 環状ボロプロリン化合物
US6979697B1 (en) 1998-08-21 2005-12-27 Point Therapeutics, Inc. Regulation of substrate activity
US6890904B1 (en) 1999-05-25 2005-05-10 Point Therapeutics, Inc. Anti-tumor agents
AU2001233622A1 (en) * 2000-02-25 2001-09-03 Novo-Nordisk A/S Inhibition of beta cell degeneration
AU2003218969A1 (en) * 2002-02-01 2003-09-02 Probiodrug Ag Modulation of t lymphocytes using dp iv inhibitors
US7317109B2 (en) 2003-11-12 2008-01-08 Phenomix Corporation Pyrrolidine compounds and methods for selective inhibition of dipeptidyl peptidase-IV
US7767828B2 (en) 2003-11-12 2010-08-03 Phenomix Corporation Methyl and ethyl substituted pyrrolidine compounds and methods for selective inhibition of dipeptidyl peptidase-IV
US7576121B2 (en) 2003-11-12 2009-08-18 Phenomix Corporation Pyrrolidine compounds and methods for selective inhibition of dipeptidyl peptidase-IV
AR046778A1 (es) 2003-11-12 2005-12-21 Phenomix Corp Compuestos heterociclicos de acido boronico. metodos de obtencion y composiciones farmaceuticas.
KR20140089408A (ko) 2003-11-17 2014-07-14 노파르티스 아게 디펩티딜 펩티다제 ⅳ 억제제의 용도
SI1715893T1 (sl) 2004-01-20 2009-12-31 Novartis Pharma Ag Direktna kompresijska formulacija in postopek
TW200604137A (en) 2004-04-27 2006-02-01 Wyeth Corp Coupling process for generating reactive boron-containing derivatives of n-substituted pyrrole-2-carbonitriles to produce biaryls
DOP2006000008A (es) 2005-01-10 2006-08-31 Arena Pharm Inc Terapia combinada para el tratamiento de la diabetes y afecciones relacionadas y para el tratamiento de afecciones que mejoran mediante un incremento de la concentración sanguínea de glp-1
US7399869B2 (en) 2005-05-19 2008-07-15 Genentech, Inc. Fibroblast activation protein inhibitor compounds and methods
US7825139B2 (en) 2005-05-25 2010-11-02 Forest Laboratories Holdings Limited (BM) Compounds and methods for selective inhibition of dipeptidyl peptidase-IV
CN1331835C (zh) * 2005-10-18 2007-08-15 武汉大学 光活性β-羟基酮的制备方法
CA2633803A1 (en) * 2005-12-19 2007-09-07 Trustees Of Tufts College Soft protease inhibitors and pro-soft forms thereof
PE20071221A1 (es) 2006-04-11 2007-12-14 Arena Pharm Inc Agonistas del receptor gpr119 en metodos para aumentar la masa osea y para tratar la osteoporosis y otras afecciones caracterizadas por masa osea baja, y la terapia combinada relacionada a estos agonistas
AU2007238805B2 (en) 2006-04-11 2012-04-05 Arena Pharmaceuticals, Inc. Methods of using GPR119 receptor to identify compounds useful for increasing bone mass in an individual
EP2108960A1 (en) 2008-04-07 2009-10-14 Arena Pharmaceuticals, Inc. Methods of using A G protein-coupled receptor to identify peptide YY (PYY) secretagogues and compounds useful in the treatment of conditons modulated by PYY
EP2730580A1 (en) * 2008-06-17 2014-05-14 Millennium Pharmaceuticals, Inc. Boronate ester compounds and pharmaceutical compositions thereof
AR077642A1 (es) 2009-07-09 2011-09-14 Arena Pharm Inc Moduladores del metabolismo y el tratamiento de trastornos relacionados con el mismo
JP2013523819A (ja) 2010-04-06 2013-06-17 アリーナ ファーマシューティカルズ, インコーポレイテッド Gpr119レセプターのモジュレーターおよびそれに関連する障害の処置
PH12013500547A1 (en) 2010-09-22 2013-06-10 Arena Pharm Inc Modulators of the gpr119 receptor and the treatment of disorders related thereto
US20140018371A1 (en) 2011-04-01 2014-01-16 Arena Pharmaceuticals, Inc. Modulators Of The GPR119 Receptor And The Treatment Of Disorders Related Thereto
WO2012145361A1 (en) 2011-04-19 2012-10-26 Arena Pharmaceuticals, Inc. Modulators of the gpr119 receptor and the treatment of disorders related thereto
WO2012145603A1 (en) 2011-04-22 2012-10-26 Arena Pharmaceuticals, Inc. Modulators of the gpr119 receptor and the treatment of disorders related thereto
WO2012145604A1 (en) 2011-04-22 2012-10-26 Arena Pharmaceuticals, Inc. Modulators of the gpr119 receptor and the treatment of disorders related thereto
WO2012170702A1 (en) 2011-06-08 2012-12-13 Arena Pharmaceuticals, Inc. Modulators of the gpr119 receptor and the treatment of disorders related thereto
WO2013055910A1 (en) 2011-10-12 2013-04-18 Arena Pharmaceuticals, Inc. Modulators of the gpr119 receptor and the treatment of disorders related thereto
WO2014074668A1 (en) 2012-11-08 2014-05-15 Arena Pharmaceuticals, Inc. Modulators of gpr119 and the treatment of disorders related thereto
US9523687B2 (en) 2014-02-28 2016-12-20 Institut Pasteur Levels of CXCL 10/IP-10 forms and soluble CD26/DPPIV activity as early predictive biomarkers for HIV/SIV associated mucosal inflammation and progression towards AIDS
KR102509950B1 (ko) 2014-05-20 2023-03-14 밀레니엄 파머슈티컬스 인코퍼레이티드 일차 암 치료법 후 사용하기 위한 붕소-함유 프로테아좀 저해제
MX386778B (es) 2015-03-09 2025-03-19 Intekrin Therapeutics Inc Métodos para el tratamiento de enfermedad de hígado graso no alcohólico y/o lipodistrofia.
WO2018162722A1 (en) 2017-03-09 2018-09-13 Deutsches Institut Für Ernährungsforschung Potsdam-Rehbrücke Dpp-4 inhibitors for use in treating bone fractures
CA3058806A1 (en) 2017-04-03 2018-10-11 Coherus Biosciences Inc. Ppar.gamma. agonist for treatment of progressive supranuclear palsy
CN108047257B (zh) * 2017-12-17 2020-03-13 沧州普瑞东方科技有限公司 一种手性n-boc-吡咯烷-2-硼酸的制备工艺
KR102635698B1 (ko) * 2018-02-20 2024-02-14 오츠카 세이야쿠 가부시키가이샤 4-보로노페닐알라닌 제조 방법
CN110452258B (zh) * 2019-09-03 2021-01-01 上海馨远医药科技有限公司 一种二肽缬氨酸硼脯氨酸盐的制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4935493A (en) * 1987-10-06 1990-06-19 E. I. Du Pont De Nemours And Company Protease inhibitors
DK0528858T3 (da) * 1990-04-14 1997-07-28 Univ Tufts Med Inhibitorer af dipeptidyl-aminopeptidase type IV
GB9017694D0 (en) * 1990-08-13 1990-09-26 Sandoz Ltd Improvements in or relating to organic chemistry

Also Published As

Publication number Publication date
SK59294A3 (en) 1995-02-08
TW232697B (en:Method) 1994-10-21
NO941905D0 (no) 1994-05-20
HU9401350D0 (en) 1994-08-29
CZ124494A3 (en) 1995-07-12
MX9206628A (es) 1993-05-01
SI9200332A (en) 1993-06-30
IL103817A0 (en) 1993-04-04
EP0641347A1 (en) 1995-03-08
AU3136893A (en) 1993-06-15
FI942345A7 (fi) 1994-05-20
WO1993010127A1 (en) 1993-05-27
NO941905L (no) 1994-07-14
HUT67937A (en) 1995-05-29
FI942345A0 (fi) 1994-05-20
NZ245207A (en) 1994-07-26
AU661362B2 (en) 1995-07-20
JPH07501078A (ja) 1995-02-02
CA2123128A1 (en) 1993-05-27
CN1073946A (zh) 1993-07-07

Similar Documents

Publication Publication Date Title
PT101079A (pt) Processo para a preparacao de esteres prolinaboronatos
KR100939598B1 (ko) 붕소산 에스테르와 산 화합물의 합성
JP2022068192A (ja) 銅およびニッケル触媒による脱炭酸ホウ素化反応
Harris et al. Synthesis of 3S-pyrrolidinol from L-glutamic acid
US4853476A (en) Phosphorus containing compounds as inhibitors of enkephalinases
KR890000769B1 (ko) 프롤린 유도체의 제법
US5393912A (en) D-myo-inositol 1,4,5-trisphosphate analogues
Armstrong et al. Enantioselective Synthesis of α-Aminophosphonates via Organocatalytic Sulfenylation and [2, 3]-Sigmatropic Sulfimide Rearrangement
KR890000770B1 (ko) 프롤린 유도체의 제법
Terzis et al. Preparation of pseudo-arsonolipids: 2-acyloxypropane-1, 3-bis (arsonic acids). The crystal structure of 2-hydroxypropane-1, 3-bis (arsonic acid)
JPS5940839B2 (ja) 混合酸型1,2−ジアシル−3−グリセリルホスホリルコリン類の製法
EP0050799B1 (en) New processes for the production of di-alkyl esters and optically active mono-alkyl esters of 3-aminoglutaric acid
HK40066099B (en) Synthesis of boronic ester and acid compounds
HK40066099A (en) Synthesis of boronic ester and acid compounds
Phelps et al. Synthesis of chromophoric dehydro analog of leucine enkephalin
KR101093417B1 (ko) 트리플루오로아세틸 숙신이미드에스터의 제조방법
Snider et al. Synthesis of Deoxytabtoxinine-β-Lactam
Fabry-Asztalos Asymmetric synthesis of organoboron compounds bearing peptides and other nitrogen containing substituents
Lee Inhibition and reaction mechanism of acetylcholinesterase-catalyzed hydrolysis of thioesters
IE75735B1 (en) Excitatory amino acid antagonists
CN1094719A (zh) 新颖的光学活性化合物及其制备方法
CN1070640A (zh) 新颖的光学活性化合物的制备方法
JPS62205070A (ja) アミノエポキシアルコ−ル誘導体

Legal Events

Date Code Title Description
BB1A Laying open of patent application

Effective date: 19930715

FC3A Refusal

Effective date: 19990607